# SymBiosis Capital Partners, LLC: Form 13F holdings

An institutional investment manager in BENTONVILLE, AR. SEC CIK 2006045.

- Quarter ended: 2026-03-31
- Filed: 2026-05-12
- Reported value: $52.8m
- Positions: 6 (6 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: not compared; the manager did not file for the quarter before
- Filing: https://www.sec.gov/Archives/edgar/data/2006045/000200604526000007/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Mar 31, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [Evommune, Inc. (EVMN)](/companies/evmn.md) | COM SHS | $29.4m | 55.8% | 1,280,778 |  | Not compared |
| [Inventiva S.A. (IVA)](/companies/iva.md) | ADS | $13.1m | 24.8% | 2,354,000 |  | Not compared |
| Wave Life Sciences Ltd. | SHS | $5.4m | 10.3% | 750,000 |  | Not compared |
| [Rani Therapeutics Holdings, Inc. (RANI)](/companies/rani.md) | COM CL A | $2.7m | 5.1% | 3,667,585 |  | Not compared |
| [Clene Nanomedicine Inc. (CLNN)](/companies/clnn.md) | COM NEW | $2.1m | 4.0% | 431,094 |  | Not compared |
| Surrozen, Inc. | \*W EXP 08/01/203 | $2.4k | <0.1% | 150,000 |  | Not compared |

Source: SEC EDGAR, Form 13F-HR, accession 0002006045-26-000007. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.